Breakthrough drugs for the interface between psychiatry and neurology

Affiliations

Editorial

L Citrome. Int J Clin Pract.2016 Apr.

No abstract available

Similar articles

[Complex neurotropic drugs and the problem of optimizing of pharmacotherapy in neurology].
Burchinskiĭ SG.Burchinskiĭ SG.Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(8):71-4.Zh Nevrol Psikhiatr Im S S Korsakova. 2008.PMID:19117079Russian.No abstract available.
Editorial: central nervous system drugs in the treatment of neurological disorders.
Samsam M.Samsam M.Cent Nerv Syst Agents Med Chem. 2012 Sep;12(3):153-7. doi: 10.2174/187152412802430101.Cent Nerv Syst Agents Med Chem. 2012.PMID:22894608Review.No abstract available.
Neuroanesthesiology review--2005.
Pasternak JJ, Lanier WL.Pasternak JJ, et al.J Neurosurg Anesthesiol. 2006 Apr;18(2):93-105. doi: 10.1097/00008506-200604000-00002.J Neurosurg Anesthesiol. 2006.PMID:16628062Review.No abstract available.
Medicines for the mind: policy-based "pull" incentives for creating breakthrough CNS drugs.
Choi DW, Armitage R, Brady LS, Coetzee T, Fisher W, Hyman S, Pande A, Paul S, Potter W, Roin B, Sherer T.Choi DW, et al.Neuron. 2014 Nov 5;84(3):554-63. doi: 10.1016/j.neuron.2014.10.027. Epub 2014 Nov 5.Neuron. 2014.PMID:25442934Review.
Wall between neurology and psychiatry. Some parts of the wall are thicker than others.
Stone J, Carson A, Sharpe M.Stone J, et al.BMJ. 2002 Oct 5;325(7367):778.BMJ. 2002.PMID:12370967No abstract available.

The landscape of small-molecule prodrugs.
Fralish Z, Chen A, Khan S, Zhou P, Reker D.Fralish Z, et al.Nat Rev Drug Discov. 2024 May;23(5):365-380. doi: 10.1038/s41573-024-00914-7. Epub 2024 Apr 2.Nat Rev Drug Discov. 2024.PMID:38565913Review.